HomeBusinessEisai, Biogen’s Alzheimer’s drug price should not dent demand – analystsFILE PHOTO: A sign marks a Biogen facility in Massachusetts Estimated read time 1 min read FILE PHOTO: A sign marks a Biogen facility in Massachusetts FILE PHOTO: A sign marks a Biogen facility in Cambridge, Massachusetts, U.S. January 26, 2017. REUTERS/Brian Snyder
